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Introduction: Prescription errors are common problems in hospitals that lead to increase in morbidity, 
mortality and treatment cost. They also reduce faith towards healthcare providers. They are avoidable and 
their adverse outcomes can be reduced if assessed and recognized earlier. This study was conducted to 
assess prescription errors occurred in a tertiary care hospital in Nepal. Methods: A cross-sectional study was 
conducted in the Internal Medicine Department of Lumbini Medical College over five months of duration. 
Patients who were prescribed at least one drug in the prescription form were included. Results: Out of 425 
patients, prescription errors were seen in 168 (39.5%) cases. Among the prescription errors, 160 (37.6% 
of all prescriptions) were the errors of omission. Errors of omission, due to missed dose of the drug were 
observed in 111 prescriptions (26.1%). Regarding the severity of medication errors, category B errors were 
the most common (21.6%). Prescriptions to patients with one diagnosis were less likely to have prescription 
errors compared to those with more than one diagnosis (p = 0.0002). Observed frequency of prescription 
errors was higher among patients with polypharmacy (p < 0.001) and Fixed-Dose Drug Combination (p < 
0.001). The observed frequency of errors of omission was also higher among patients with more than one 
diagnosis (p = 0.0002), patients with polypharmacy (p < 0.001) and patients who were prescribed Fixed-
Dose Drug Combinations (p < 0.001). Conclusion: About one-third of the patients had prescription errors. 
Among them, errors of omission were the most common.
Keywords: Error of omission, Medication error, Prescriptions, Tertiary hospital
Original Research Articlehttps://doi.org/10.22502/jlmc.v9i1.414
Naresh Karki,a,c Kamal Kandel,b,c Pravin Prasad a,d
Assessment of Prescription Errors in the Internal 
Medicine Department of a Tertiary Care Hospital 
in Nepal: A Cross-Sectional Study
How to cite this article:
Karki N, Kandel K, Prasad P. Assessment of Prescription Errors 
in the Internal Medicine Department of a Tertiary Care Hospital in 
Nepal: A Cross-Sectional Study. Journal of Lumbini Medical College. 
2021;9(1):8pages. DOI: https://doi.org/10.22502/jlmc.v9i1.414. 
Epub: May 25, 2021.
Licensed under CC BY 4.0 International License 
which permits use, distribution and reproduction in any 
medium, provided the original work is properly cited.
INTRODUCTION:
 National Coordinating Council for 
Medication Error Reporting and Prevention 
(NCC MERP) defined medication errors (MEs) as 
“Any preventable event that may cause or lead to 
inappropriate medication use or patient harm while 
the medication is in the control of the healthcare 
professional, patient, or consumer. Such events 
may be related to professional practice, health 
care products, procedures, and systems, including 
prescribing, order communication, product labeling, 
packaging, and nomenclature, compounding, 
dispensing, distribution, administration, education, 
monitoring, and use”.[1,2] Many factors are 
responsible for generating MEs such as health 
worker’s workload, poor knowledge about drugs, 
irrational use of drugs, poor communication 
between healthcare providers and patients, pressure 
of time management, inadequate knowledge of 
disease and complexity of disease.[2] According 
to data of WHO, MEs generally produce adverse 
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effects of drugs in approximately one million people 
every year worldwide including low- and middle-
income countries.[3]  
 Among MEs, prescription errors are 
common which are of two types; errors of 
omission and errors of commission.[4] If essential 
information is missed in the prescription, it is called 
error of omission, while errors of commission occur 
if wrong information is written in the prescription.
[4] Prescription errors lead to increase in adverse 
effects of drugs, morbidities, mortalities and burden 
of treatment costs. Beside this, they also lead to 
reduced faith of patients towards healthcare providers 
and increased wastage of public money.[4,5] If 
assessments of those errors are made by authorized 
healthcare professionals in regular interval, they 
can be identified and corrected. So, in future, the 
harmful outcomes of those errors can be prevented 
and minimized.[6,7] These regular assessments also 
reduce existing gap of belief between healthcare 
providers and patients. Many studies related to 
prescription error rates have been conducted in 
hospitals worldwide, but sufficient studies are not 
available for low-and middle-income countries, 
despite those countries have increased practice of 
using medications. Moreover, only few studies have 
been found in tertiary level hospitals of Nepal.[4,6] 
Thus, this study was conducted with general objective 
to provide the understanding of prescription errors in 
Internal Medicine Department of Lumbini Medical 
College and Teaching Hospital (LMCTH). While 
the specific objectives were to evaluate  prevalence 
of prescription errors that include errors of omission 
as well as errors of commission, to assess the 
level of severity of medication errors and to study 
their association with socio-demographic/clinical 
characteristics of the patients.
METHODS:
 A cross sectional study was conducted 
in Internal Medicine Department of LMCTH, 
Tansen, Palpa after an approval letter was received 
from Institutional Review Committee (Protocol 
No: IRC-LMC 14-G/020). An approval letter was 
also received from the Head of the Department of 
Internal Medicine to conduct the study. The study 
was conducted for the duration of five months from 
August, 2020 to January, 2021. The study included 
the data of: patient who visited the Internal Medicine 
Out-Patient Department (OPD) irrespective of age, 
gender and diagnosis, patient encountered first time 
by researchers, follow up patient encountered first 
time by researchers and patient prescribed at least 
one drug in OPD prescription form. While, follow 
up patient encountered previously during first visit, 
patient prescribed no drug in OPD prescription form 
and patient treated in Internal medicine In-Patient 
department were excluded.
 The sample size was calculated using the 
following formula (when population was unknown) 
as demonstrated in the articles published by Sheikh 
et al. and Degu et al.[7,8]: 
N = Z2 P (1-P) / d2
Where, 
N = Minimum sample size required for accuracy in 
estimating proportions 
Z = Standard normal value for 95 % confidence 
interval (1.96),
P = Proportion of population possessing 
characteristics of interest, 0.5 (50%), 
1-P = Proportion of population that do not possess 
the characteristics of interest,
d = Margin of sampling error tolerated, 0.05 (5%)
Hence, the minimum sample size required was 384.
A convenience sampling technique was used for 
collection of the data. The primary data were 
collected from Health Insurance Section of LMCTH 
and recorded in pre-designed Case-Proforma. The 
Case-Proforma consisted of information about 
socio-demographic profile of patients, diagnosis of 
disease and findings related to prescription errors. 
Each prescription was checked two times to find if 
prescription contained any error. All the processes 
were done by researchers themselves. All the data 
were kept confidential and anonymous by keeping 
code numbers in place of name and address of the 
patient. However, hospital numbers were recorded 
for the proof that data were original. 
 Prescription errors namely errors of omission 
and errors of commission were included in Case-
Proforma as found in the study conducted by Ansari 
et al., Sheikh et al., and Sapkota et al.[6,7,9]:
1. Errors of omission (Essential information is 
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missed in the prescription form.):
- Related to prescriber
•	 Patient name not mentioned
•	 Age not mentioned
•	 Prescription date not mentioned
•	 Diagnosis not mentioned
•	 Prescriber name not mentioned 
•	 Department not mentioned
•	 Prescriber signature not mentioned
- Related to drugs per total medicine dispensed
•	 Dose not mentioned 
•	 Frequency not mentioned
•	 Dosage form not mentioned
•	 Quantity to supply not mentioned
2. Errors of commission (Wrong information is 
written in the prescription form, some examples 
of which are given below.):
The possible causes for this type of errors are 
high workload of doctors, distraction of mind 
due to multiple duties of doctors, time pressure 
because of increased numbers of patients 
visiting to the OPD and interruption by patients, 
patient’s relatives and other hospital staffs while 
prescribing the drugs).   
•	 Wrong strength (Example: Dose of thyroxine is 
written in milligram in place of microgram)
•	 Wrong drug name (Example; Metoprolol is 
written in place of metronidazole)
•	 Wrong Dosage form
•	 Potential drug-drug interaction
 Both errors of omission and errors of 
commission made in the act of writing the 
prescription form were analyzed. The treatment 
guidelines for the disease or medical decisions were 
not taken into consideration during assessment of 
errors. 
 Further, level of severity of the medication 
errors was assessed by using internationally 
validated NCCMERP index.[2,10] This index 
contains nine categories from category A to category 
I as described below:
•	 Category A: Circumstances that have potential 
to cause medication errors. This circumstance 
causes no harm to the patients.
•	 Category B: An error occurs but does not reach 
the patient. This error causes no harm to the 
patient.
•	 Category C: An error occurs and reaches the 
patient but does not cause any harm to the patient.
•	 Category D: An error occurs that reaches the 
patient and needs monitoring to confirm that the 
error causes no harm to the patient. This error 
also requires intervention to prevent harm.
•	 Category E: This category includes error that 
may contribute or result in temporary harm. 
These errors may require intervention to prevent 
them.
•	 Category F: An error occurs that may contribute 
to or result in temporary harm and requires initial 
or prolong hospitalization of patient.
•	 Category G: An error occurs that may contribute 
to result in permanent harm to the patients.
•	 Category H: An error occurs that requires 
intervention necessary to sustain life.
•	 Category I: An error occurs that contributes or 
causes the patient’s death. 
 Once data were collected, they were 
entered in and analyzed by Statistical Package 
for Social Sciences (SPSS), version 18. Basic 
socio-demographic variables (age, sex, ethnicity 
of the patients), clinical characteristics (presence 
of multiple illnesses, prescription of five or more 
drugs i.e. polypharmacy, prescription of Fixed-Dose 
Drug Combinations) were described. Prescription 
errors and their associations with various socio-
demographic and clinical characteristics were then 
analyzed. Categorical variables were expressed as 
frequency and percentage. Continuous variables 
were reported in terms of mean and standard 
deviation (SD). For inferential statistics, independent 
t-test and chi-square test were used as appropriate. p 
value less than 0.05 was considered as statistically 
significant. 
RESULTS:
 A total of 425 prescription forms were 
observed. Of them, 53.4% were of males and 
69.2% patients were above 50 years of age (Table 
1). Mean age ± SD of patients was 57.4 ± 16.9 
years. Moreover, 56.2% of patients were found 
with more than one diagnosis and 46.8% of total 
patients were prescribed five or more than five 
drugs (polypharmacy) as shown in Table 1. Fixed-
Dose Drugs Combinations (FDC) were found to be 
prescribed to 49.2% of the patients (Table 1). The 
most common FDC was Salmeterol + Fluticasone 
(12%) followed by Amlodipine + Losartan (10.1%)
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Table 1. Socio-demographic and clinical 
characteristics of patients (N = 425).
Characteristics Numbers (%) Statistics














Mean age of 
female ± SD (in 
years)
Mean age of male 
± SD (in years)
56.3 ± 17.3 
58.4 ± 16.5
t = -1.29, 
df = 
409.71, p = 
0.198








More than one 239 (56.2)
Polypharmacy
Five or more than 
five drugs
199 (46.8)














 In 168 (39.5%) patients prescription errors 
were seen. Among prescription errors, 160 (37.6%) 
patients were found with error of omission and 13 
(3.1%) patients with errors of commission. Five 
patients were found with both errors of omission 
and errors of commission. Average number of 
medication errors per prescription was 1.60 ± 0.48. 
Furthermore, among errors of omission, dose of the 
drug was not mentioned in 111 (26.1%) patients, 
while among error of commission wrong dose was 
prescribed in 12 (2.8%) patients (Table 2). The level 
of severity of medication error, according to NCC 
MERP Index, was analyzed and it showed Category 
B in 92 (21.6%) patients, Category A in 74 (17.4%) 
and Category C in 2 (0.5%).
 Patients with only one diagnosis were less 
likely to be found with prescription errors compared 
to the patients with more than one diagnosis (X2[N 
= 425, df = 1] = 13.72, p = 0.0002) as demonstrated 
in Table 3. The prescription errors were more likely 
presented among patients with polypharmacy 
compared to patients without polypharmacy. This 
association was found statistically significant (X2[N 
= 425, df = 1] = 25.37, p < 0.001). Patients who 
were prescribed FDC were more likely found with 
prescription errors compared to patients who were 
not prescribed FDC (X2[N = 425, df =1] = 43.89, 
p < 0.001) as shown in Table 3. Similarly, errors 
of omission were more likely presented among 
patients with more than one diagnosis compared 
to one diagnosis (X2[N = 425, df =1] = 13.23, p 
= 0.0002), among patients with polypharmacy 
compared to patients without polypharmacy (X2[N = 
425, df =1] = 23.34, p < 0.001) and among patients 
who prescribed FDC compared to patients without 
prescribing FDC (X2[N = 425, df =1] = 41.88, p < 
0.001) as demonstrated in Table 3
DISCUSSION:
 The aim of this study was to provide the 
understanding of prescription errors in Internal 
Medicine Department of a tertiary care hospital. In 
our study, about two-third of the patients were above 
50 years of age. The reason behind this might be 
that the data were collected during the COVID-19 
pandemic and the majority of the patients were the 
follow up patients with the diagnosis of chronic 
health conditions like hypertension, diabetes, chronic 
obstructive pulmonary diseases etc. who visited 
the hospital to refill the drugs under their health 
insurance scheme. Our study demonstrated almost 
equal distribution of the genders with male to female 
ratio 1.1:1. The average number of drugs prescribed 
per encounter was 4.4 ± 2.2. This finding was higher 
than the average number of drugs prescribed per 
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Table 2. Distribution of prescriptions errors among patients (N = 425)
Error of omission
Related to prescriber Related to drugs per total medicine dispensed
Variables n (%) Variables n (%)
Patient name not mentioned 0 (0) Dose not mentioned 111 (26.1)
Age not mentioned 0 (0) Frequency not mentioned 0 (0)
Prescription date not mentioned 0 (0) Dosage form not mentioned 23 (5.4)
Diagnosis not mentioned 0 (0) Quantity to supply not mentioned 0 (0)
Prescriber name not mentioned 21 (4.9)
Department not mentioned 0 (0)
Prescriber signature not mentioned 5 (1.2)
Errors of Commission
Variables n (%)
Wrong strength or dose 12 (2.8)
Wrong drug name (not spelling) 0 (0)
Wrong Dosage form 0 (0)
Drug-drug Interaction    1 (0.2)
Table 3. Association of socio-demographic and clinical characteristics with prescription errors, errors of 
omission and errors of commission
Characteristics Medication errors Errors of Omission Errors of Commission
Yes No Statistics Yes No Statistics Yes No Statistics
Age (in years)
   ≤ 50 38 93 X2 = 8.77, 
df = 1, p = 
0.003
35 96 X2=9.63 df 
= 1, p = 
0.002
5 126 p = 0.550
>50 130 164 125 169 8 286
Gender
Female 80 118 X2 = 0.11, 
df = 1, p = 
0.731
77 121 X2 = 0.24, 
df = 1, p = 
0.622
7 191 X2 = 0.28, df =1, 
p = 0.594   Male 88 139 83 144 6 221
Number of 
Diagnosis
   One 55 131 X2 = 13.72, 
df = 1, p = 
0.0002
52 134 X2 = 13.23, 
df = 1, p = 
0.0002
 3 183 X2 = 2.33, df = 1, 
p = 0.127> One 113 126 108 131 10 229
Polypharmacy
≥ Five drugs 104 95 X2 = 25.37, 
df = 1, P < 
0.001
99 100 X2 = 23.34, 
df = 1, p < 
0.001
8 191 X2 = 1.16, df = 1, 




Prescribed 116 93 X2 = 43.89, 
df = 1, p < 
0.001
111 98 X2 = 41.88, 
df = 1, p < 
0.001
9 200 X2 = 2.15, df = 1, 
p = 0.142Not prescribed 52 164 49 167 4 212
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encounter calculated by using WHO prescribing 
indicators. The ideal WHO value is 2.[11] This 
finding was also nearly reflecting the practice of 
polypharmacy. Polypharmacy is the concurrent use 
of multiple drugs; five or more than five.[12] This 
practice is likely while prescribing drugs among 
old aged persons because they have higher chances 
to be affected by multiple diseases. Furthermore, 
polypharmacy may cause prescription errors by 
healthcare providers because when more numbers of 
medicines are prescribed, chances of creating errors 
are also higher. 
 In this study, prescription errors were 
observed in about one-third of the patients. The 
findings of a few studies were dissimilar to our 
study, where more than two-third of the patients 
had prescription errors.[13,14]However, two studies 
had demonstrated  results related to the frequency 
of prescription errors similar to  our study.[15,16] 
Prescription errors occur from circumstances like 
mistakes, lapses and slips.[1] They are avoidable 
and can be minimized if assessed by clinical 
pharmacologists because they have deep knowledge 
of medicines, their therapeutic responses, their 
adverse effects and drug interactions.[1,3] So the 
team of clinical pharmacologists, doctors, nurses, 
paramedics and administration personnel will 
become effective if they work collectively to achieve 
common goal of preventing or minimizing  errors 
during drug prescriptions.
 Among the prescription errors, our study 
displayed that errors of omission were higher. The 
similar types of results have been found in some 
studies.[4,7,8,14,15,17] The reason behind this may 
be that, in majority of those prescriptions, doses 
of drugs and prescriber’s name/signatures were 
missing because of pressure of increased numbers 
of patients visited to OPD, increased workload 
and mismanagement of time. Whereas, few studies 
contradicted with our findings that showed errors 
of commission were predominant.[13,18] Among 
errors of omission, dose of the drugs was not 
mentioned in about one-fourth of prescriptions. 
The reason for this finding was that the doses of 
the drugs were missed in one of the drugs of FDC. 
For example, in our study, fixed dose combination 
of salmaterol and fluticasone was commonly 
prescribed. In prescription form, dose of salmaterol 
was mentioned, but dose of fluticasone was missed 
to mention. To avoid prescription errors, doses of 
both drugs of FDC should be written. Prescription 
errors may occur unknowingly while working 
under unfavorable environment. Awareness of the 
possibility of such prescription errors may be useful 
to minimize the same in the future. 
 To the researcher’s best knowledge, only one 
potential event that may cause drug-drug interaction 
was observed in our study. In contrast to our study 
Shrestha et al. and Pote et al. found that there were 
higher numbers of drug-drug interactions (10.2% 
and 68.2% respectively).[4,16] However, drug 
interaction found in our study did not have potential 
to cause any harm to the patient. The potential drug 
interaction was between sucralfate and proton pump 
inhibitor. This drug interaction reduces therapeutic 
response of sucralfate because proton pump inhibitor 
raises pH of stomach to more than 5. Hence, the 
effect of sucralfate is reduced because it acts at 
pH less than 5. Drug-drug interactions should not 
be ignored because they have potential to diminish 
therapeutic response, produce adverse effects or 
even fatal problems.[9] They should be evaluated 
with special attention in order to prevent them.
 Moreover, our study also demonstrated that 
more than one-third of all of the cases showed some 
levels of severity of medication error according to 
NCC MERP Index. The majority of errors belonged 
to Category B (21.6%) followed by Category A and 
Category C but none to more severe categories. One 
study conducted by Shrestha et al. supported finding 
of our study and demonstrated that about two-third 
of errors belonged to Category B.[14] Whereas, 
in contrast to our study, some studies showed that 
majority of errors belonged to Category C.[7,15,18] 
In NCC MERP Index, Category A defines “any 
circumstances that have the capacity to cause error”, 
while Category B indicates that “an error occurred 
but it did not reach the patient”.[2] According to 
NCC MERP Index Category A, B, C and D do not 
cause any harm to the patient, while Category E, 
F, G, H and I cause temporary harms or permanent 
harms or even death of patients[2,9] 
 Single out-patient department-based study 
design, short duration of the study and convenience 
sampling method are the limitations of our 
study. Besides this while analyzing the errors of 
commission, we assessed only the errors made in 
the act of writing the prescription regardless of the 
medical decision made.
CONCLUSION:
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 Our study found that about one-third of 
patients had prescription errors. Among them, 
errors of omission were the most common. Errors 
of omission were more likely among patients who 
were prescribed five or more than five drugs, who 
were diagnosed with more than one disease and who 
were prescribed fixed-dose drugs combinations. We 
suggest that collaborative program be conducted 
among the physicians, clinical pharmacologists, 
nursing staff, paramedical staff and hospital 
administration as an effort to minimize prescription 
errors as this practice has been supported by previous 
studies.
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